期刊文献+

池州地区大肠埃希菌和肺炎克雷伯菌产超广谱β-内酰胺酶的基因型分布 被引量:6

Genotype distribution of extended-spectrum β-lactamases in ESBLs-producing escherichia coli and klebsiella pneumoniac in Chizhou
下载PDF
导出
摘要 目的研究池州地区分离的大肠埃希菌(E.coli)和肺炎克雷伯菌(K.pn)质粒编码的产超广谱β-内酰胺酶(ES-BLs)基因分布情况。方法收集大肠埃希菌152株,肺炎克雷伯菌36株,采用美国临床实验室标准委员会(NCCLS)规定的ESBLs表型筛选和确证试验,确定本地区ESBLs的发生率,并通过特异性引物、聚合酶链反应(PCR)反应、及核酸电泳分析上述菌株所携带的耐药基因并进行基因分型。结果本地区17.1%的大肠埃希菌27.7%肺炎克雷伯菌产ESBLs,其中大肠埃希菌耐药质粒编码TEM型,SHV型和非TEM,SHV型基因的百分率分别为:65.4%,26.9%,7.7%,肺炎克雷伯菌分别为20%,40%,40%。结论本地区临床分离产ESBLs大肠埃希菌和肺炎克雷伯菌耐药情况严重,且其耐药表型也不尽相同。临床上严格控制和合理使用抗生素已经刻不容缓。 Objective To study the genotype distribution of ESBLs about Escherichia coli and Klebsiella pneumoniac in Chizhou.Methods To collect 152 Escherichia coli and 36 Klebsiella pneumoniac and using the method of National Committee for Clinical Laboratory Standards to filt and ascertainment the Escherichia coli and Klebsiella pneumoniac with ESBLs.Extraction the plasmid of the bacterium with ESBLs,and amplification by polymerase chain reaction were applied.Nucleate electrophoretic analysis genotyping of ESBLs.Results The percent of Escherichia coli ESBLs positive is 17.1%,Klebsiella pneumoniac is 27.7%.Among the Escherichia coli typing TEM is 65.4% typing SHV is 26.9% remnan is 7.7%.Among the Klebsiella pneumoniac typing TEM is 20% typing SHV is 40% remnan is 40%.Conclusion ESBLs-producing E.coli and K.pneumoniae strains isolated from Chizhou are highly resistant.Their resistance phenotypes were different.The use of antibiotic must be controlled and rational use antibiotic at clinical.
出处 《安徽医学》 2011年第9期1313-1315,共3页 Anhui Medical Journal
基金 池州市科技局社会发展科技计划资助项目
关键词 大肠埃希菌 肺炎克雷伯菌 超广谱Β-内酰胺酶 基因型 Escherichia coli Klebsiella pneumoniac ESBLs Genotype
  • 相关文献

参考文献12

  • 1Ranjbar R,Giovanni M,Giammancol.Characterization of the first extended-spectrum β-lactamase-producing nontyphoidal salmonella strains isolated in tehran,Iran.Food-Borne Pathogens Disease,2010,7 (1):91-95.
  • 2陶勇,姚杰,贾建安,吕晴.856株下呼吸道感染肠杆菌科细菌的ESBLs检测及相关分析[J].临床肺科杂志,2009,14(5):614-615. 被引量:8
  • 3郭普.医院感染病原菌分布及耐药分析[J].中华医院感染学杂志,2008,18(3):445-447. 被引量:44
  • 4Jesus RB,Juan A,Jose MC,et al.Escherichia coli producing SHV-type extended-spectrum β-lactamase is a signi? cant cause of community-acquired infection.Antimicrobial Chemother,2009,63 (17):781-784.
  • 5Jean RZ,Olivier L,Claude M,et al.Addressing the challenge of extended-spectrum β-lactamases.Curr Opin Invest Drugs,2009,10(2):172-180.
  • 6Patrick DJ,Sturm TM,Bochum Els,et al.Prevalence,Molecular characterization,and phenotypic con? rmation of extended-spectrum β-lactamases in Escherichia coli,Klebsiella pneumoniae,and klebsiella oxytoca at the radboud university nijmegen medical centre in the netherlands. Microb Drug Resist,2010,16(1):55-59.
  • 7Annemieke S,Martel AN,Davy P,et al.Characterization of extended-spectrum β-lactamases produced by escherichia coli isolated from hospitalized and nonhospitalized patients:emergence of CTX-M-15-producing strains causing urinary tract infections.Microb Drug Resist,2010,16(2):129-134.
  • 8King TL,Rohani Y,Chew CY,et al.Characterization of multidrμg resistant ESBL-producing escherichia coli isolates from hospitals in Malaysia.J Biomed Biotechnol,2009,12(4):45-55.
  • 9Juliette S,Kuntaman MM,Kuntaman NI,,et al.Molecular characterization of extended-spectrum β-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya,Indonesia.J Antimicrob Chemother,2010,65 (6):465-469.
  • 10Fei zabadi MM,Delfani S,Raji N,et al.Distribution of blaTEM,blaSHV,blaCTX-M genes among clinical isolates of Klebsiella pneumoniae at Labbafi nejad hospital,Tehran,Iran.Microb Drug Resist,2010,16(1):49-53.

二级参考文献25

共引文献51

同被引文献54

  • 1章清,魏丽,魏光美,苗群.大肠埃希菌、肺炎克雷伯菌的耐药性变迁[J].中华医院感染学杂志,2004,14(2):220-222. 被引量:19
  • 2季淑娟,陈亚岗,俞云松,周伟琳,李家斌,李兰娟.浙江省产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌的基因分型[J].中华传染病杂志,2005,23(2):75-78. 被引量:57
  • 3叶惠芬,陈惠玲,刘平,徐邦牢,江庆澜.产ESBLs大肠埃希菌和肺炎克雷伯菌耐药性和基因型分布[J].中国感染与化疗杂志,2007,7(2):127-129. 被引量:11
  • 4Clinical and laboratory standards institute. Performance standards for an- timicrobial susceptibility testing; twentieth informational supplement [ S]. MIO0 - $20,2010,30( 1 ) :40 -41.
  • 5Smet A, Martel A, Persoons D, et al. Characterization of extended - spec- trum beta - lactamases produced by Escherichia coli isolated from hospi- talized and nonhospitalized patients:Emergence of CTX - M - 15 - pro- ducing strains causing urinary tract infections [ J ]. Microb Drug Resist, 2010,16(2) :129 - 134.
  • 6Oksiiz L, Gtirler N. Typing of extended - spectrum beta - lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid pro- files[ J]. Mikrobiyol Bu1,2009,43 ( 2 ) : 183 - 194.
  • 7Mishra B,Leishangthem GD,Gill K,et al.A novel antimicrobial peptide derived from modified n-terminal domain of bovine lactoferrin:design,synthesis,activity against multidrug-resistant bacteria and Candida[J].Biochim Biophys Acta,2013,1828(2):677-686.
  • 8Spellberg B,Guidos R,Gilbert D. The epidemic of antibiotic-resistant infections:a call to action for the medical communityfrom the infectious diseases society of america[J].Clinical Infectious Diseases,2008,(02):155-161.
  • 9Quale JM,Landman D,Bradford PA. Molecular epidemiology of a city wide outbreak of extended-spectrum be-ta-lactamase-producing Klebsiella pneumoniae infection[J].Clinical Infectious Diseases,2002,(07):834-841.
  • 10Patrick DJ,Sturm ET,Bochum M. Prevalence,molecular characterization,and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli,Klebsiella pneumoniae,and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in the netherlands[J].Microbial Drug Resistance-Mechanisms Epidemiology and Disease,2010,(01):55-60.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部